Gender‑Affirming Treatment & Procedures - EHP
Customize your policy alerts
Sign up for johns_hopkins_health_plans Policy CMS24.08 alerts
Get alerted when Policy CMS24.08 changes without checking for updates manually.
Monitor payer policy activity
This policy governs authorization and coverage criteria for gender-affirming medical and surgical treatments and adjunctive procedures for members of Johns Hopkins Employer Health Programs (EHP). It describes diagnostic requirements, age-specific criteria, covered procedures, exclusions, and related considerations (e.g., fertility, hormones).
No material clinical or coverage changes in this revision.
Coverage Criteria for Gender-Affirming Care
Diagnosis of Gender Dysphoria (Adolescents and Adults)
Covered when ALL of the following DSM-5-TR diagnostic criteria are met
Indicators include: (i) incongruence with primary/secondary sex characteristics (or anticipated characteristics in young adolescents); (ii) strong desire to be rid of primary/and/or secondary sex characteristics or to prevent their development; (iii) strong desire for the primary/and/or secondary sex characteristics of another gender; (iv) strong desire to be of another gender; (v) strong desire to be treated as another gender; (vi) strong conviction of having the typical feelings/reactions of another gender.
Adult Surgical Eligibility (Breast/Chest/Genital/Adjunctive Surgery)
Covered when ALL of the following are met
Policy allows exception if hormone therapy is not desired or is medically contraindicated.
Adolescent Surgical Eligibility
Covered on case-by-case basis when ALL of the following are met
The hormone requirement does not apply to gender-affirming mastectomy.
Covered Procedures (Adults) - Breast/Chest/Genital/Reconstructive/Adjunctive
When benefits are provided under the member's contract and eligibility criteria are met, the following procedures may be considered covered:
Phalloplasty is marked with an asterisk in the policy.
Adolescent Coverage Note
Certain procedures for adolescents may be considered on a case-by-case basis
Phalloplasty is an exception and is not considered for adolescents.
Medical necessity and multidisciplinary determination
Covered when clinical and multidisciplinary criteria are met per referenced guidelines
Guidance emphasizes interdisciplinary coordination, collaboration between mental health, endocrine, primary care and surgical teams, and multidisciplinary assessment especially for adolescents and genital surgery.
Adolescent criteria
Adolescent care considerations
WPATH SOC-8 and Endocrine Society recommendations cited; phalloplasty is not recommended for youth under 18 due to complexity and high complication rates.
Unless the member's contract specifically provides otherwise, Johns Hopkins Health Plans considers certain gender-affirming procedures to be cosmetic and not medically necessary. These expressly include: revision or repeat adjunctive surgery intended solely to perfect appearance, and any surgery or procedure performed for the purpose of reversing the appearance of normal aging. (See exclusions; benefits apply only if the member’s SPD/contract provides coverage.)
The policy identifies a small set of procedures regarded as investigational/experimental and not covered unless the member’s contract specifically provides benefits. Examples listed are uterine transplantation and penile transplantation, which the plan states do not meet its Technology Evaluation Criteria (TEC) unless otherwise specified in the member’s benefits.
The policy references WPATH SOC-8 and pediatric evidence when discussing adolescent surgical care and notes that, given the high complexity and elevated complication rates of phalloplasty compared with other gender-affirming surgeries, phalloplasty is not recommended in youth under 18. This reflects concerns about irreversibility, technical complexity, and the need for additional cognitive and emotional maturation prior to consideration of procedures with substantial risk.
Portions of the document excerpt enumerate numerous CPT codes associated with gender-affirming, reconstructive, and adjunctive procedures but do not, in those sections, provide standalone determinations of medical necessity or explicit criteria tied to each code. The listed CPT groups (e.g., dermatologic/adjunctive codes, craniofacial/ nasal codes, and genital reconstruction/urologic codes) are presented as examples and cross-references within the policy text; coverage remains contingent on meeting the policy’s diagnostic and procedural eligibility requirements and the member’s specific benefit plan.
The policy includes a set of HCPCS codes (e.g., A9282, C1813, C2622, G0429, L8600) that are provided for informational purposes only. Their inclusion in the code list does not, by itself, indicate whether the services described are covered; benefit determination depends on the member’s specific SPD and applicable coverage rules.
This revision notes no changes to the policy criteria. The Summary of Changes indicates the substantive coverage criteria and exclusions remain as in the prior policy; only administrative elements (such as approval statements or table formatting) were modified in this update.
The policy explicitly states that revision/repeat adjunctive surgeries intended to perfect appearance and procedures aimed at reversing normal aging are considered cosmetic and therefore not medically necessary unless the member’s contract specifically provides coverage for those services. This exclusion aligns with the document’s general approach that cosmetic-intent procedures are not covered absent contractual benefit.
The policy includes a coding disclaimer clarifying that the inclusion of CPT and HCPCS codes in the document is informational only and does not imply coverage or guarantee reimbursement. Benefit determination is made based on the member’s specific benefit plan document (SPD) and applicable laws; inpatient admissions and other services may require preauthorization per plan rules.
Coding: CPT, HCPCS and Diagnosis Codes
| 11442 | Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 1.1 to 2.0 cm |
| 11446 | Excision, other benign lesion including margins, except skin tag (unless listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 4.0 cm |
| 11920 | Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or less |
| 11921 | Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cm |
| 11950 | Subcutaneous injection of filling material (eg, collagen); 1 cc or less |
| 11951 | Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc |
| 11952 | Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc |
| 11954 | Subcutaneous injection of filling material (eg, collagen); over 10.0 cc |
| 11960 | Insertion of tissue expander(s) for other than breast, including subsequent expansion |
| 11970 | Replacement of tissue expander with permanent implant |
| 11971 | Removal of tissue expander without insertion of implant |
| 15734 | Muscle, myocutaneous, or fasciocutaneous flap; trunk |
| 15769 | Grafting of autologous soft tissue, other, harvested by direct excision (eg, fat, dermis, fascia) |
| 15771 | Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate |
| 15772 | Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; each additional 50 cc injectate, or part thereof (List separately in addition to code for primary procedure) |
| 15773 | Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; 25 cc or less injectate |
| 15774 | Grafting of autologous fat; each additional 25 cc injectate, or part thereof (List separately in addition to code for primary procedure) |
| 15775 | Punch graft for hair transplant; 1 to 15 punch grafts |
| 15776 | Punch graft for hair transplant; more than 15 punch grafts |
| 15780 | Dermabrasion; total face (eg, for acne scarring, fine wrinkling, rhytids, general keratosis) |
| 15781 | Dermabrasion; segmental, face |
| 15789 | Chemical peel, facial; dermal |
| 15792 | Chemical peel, nonfacial; epidermal |
| 15793 | Chemical peel, nonfacial; dermal |
| 15820 | Blepharoplasty, lower eyelid |
| 15821 | Blepharoplasty, lower eyelid; with extensive herniated fat pad |
| 15822 | Blepharoplasty, upper eyelid |
| 15823 | Blepharoplasty, upper eyelid; with excessive skin weighting down lid |
| 15824 | Rhytidectomy; forehead |
| 15825 | Rhytidectomy; neck with platysmal tightening (platysmal flap, P-flap) |
| 15826 | Rhytidectomy; glabellar frown lines |
| 21122 | Genioplasty; sliding osteotomy, single piece |
| 21137 | Genioplasty; sliding osteotomies, 2 or more osteotomies (eg, wedge excision or bone wedge reversal for asymmetrical chin) |
| 21188 | Reconstruction midface, osteotomies (other than LeFort type) and bone grafts (includes obtaining autografts) |
| 21209 | Osteoplasty, facial bones; reduction |
| 21210 | Graft, bone; nasal, maxillary or malar areas (includes obtaining graft) |
| 21270 | Malar augmentation, prosthetic material |
| 30400 | Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip |
| 30420 | Rhinoplasty, primary; including major septal repair |
| 30430 | Rhinoplasty, secondary; minor revision |
| 30435 | Rhinoplasty, secondary; intermediate revision (bony work with osteotomies) |
| 53430 | Urethroplasty, 1-stage reconstruction of male anterior urethra = Urethroplasty, reconstruction of female urethra |
| 54125 | Amputation of penis; complete |
| 54400 | Insertion of penile prosthesis; non inflatable (semi-rigid) |
| 54401 | Insertion of penile prosthesis; inflatable (self-contained) |
| 54405 | Insertion of multi-component, inflatable penile prosthesis, including placement of pump, cylinders, and reservoir |
| 54406 | Removal of all components of a multi-component, inflatable penile prosthesis without replacement of prosthesis |
| 54410 | Removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis at the same operative session |
| 54660 | Insertion of testicular prosthesis (separate procedure) |
| 54690 | Laparoscopy, surgical; orchiectomy |
| 55175 | Scrotoplasty; simple |
| 57335 | Vaginoplasty for intersex state |
| 58150 | Total abdominal hysterectomy (corpus and cervix), with or without removal of tube(s), with or without removal of ovary(s) |
| 58180 | Supracervical abdominal hysterectomy (subtotal hysterectomy), with or without removal of tube(s), with or without removal of ovary(s) |
| 58260 | Vaginal hysterectomy, for uterus 250 g or less |
| 58262 | Vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or ovary(s) |
| 58275 | Vaginal hysterectomy, with total or partial vaginectomy |
| 58290 | Vaginal hysterectomy, for uterus greater than 250 g |
| 58291 | Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s) and/or ovary(s) |
| 58541 | Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less |
| 58542 | Laparoscopy, surgical, supracervical hysterectomy, for uterus 250 g or less; with removal of tube(s) and/or ovary(s) |
| F64.0 | Transsexualism |
| F64.2 | Gender identity disorder in childhood |
| F64.8 | Other gender identity disorders |
| F64.9 | Gender identity disorder, unspecified |
| Z87.890 | Personal history of sex reassignment |
Provider Actions, Authorization & Documentation
Prior authorization required
Prior authorization is required per the member's contract for gender-affirming surgical procedures; approval is contingent on meeting the diagnostic and procedure-specific criteria set forth in the policy (Procedure Number CMS24.08).
- Obtain prior authorization according to the member's SPD and the plan's authorization process before scheduling gender-affirming surgery.
- Authorization decisions depend on documented fulfillment of the policy’s diagnostic and surgical eligibility criteria.
Inpatient preauthorization required
All inpatient admissions require preauthorization; failure to obtain required preauthorization for an inpatient admission may result in denial or further review per plan rules.
- Verify inpatient authorization requirements with the member's specific SPD before admission.
- Obtain and document preauthorization prior to inpatient procedures when the service will be an inpatient stay.
Policy identification (CMS24.08); no explicit PA steps in excerpt
The policy is identified as Procedure Number CMS24.08 with approval and effective dates listed; the excerpt does not describe step-by-step prior authorization submission procedures.
- Policy identifier: CMS24.08. Approval Date: 01/20/2026. Effective Date: 04/01/2026.
- Follow plan-specific prior authorization submission processes (not detailed in this excerpt).
Prior authorization implied for listed CPT codes
The policy enumerates select CPT procedure codes for gender-affirming surgeries and related procedures; prior authorization is implied for these listed procedures and should be obtained per plan requirements.
- Examples of listed CPT codes appear in the coding sections (see policy code tables for full lists).
- Obtain prior authorization when billing any of the enumerated CPT codes for gender-affirming services under the member's plan.
Policy approval and follow plan PA processes
This policy was approved by MPAC and becomes effective 04/01/2026; providers should follow the policy and the member’s plan documents for prior authorization and approval processes.
- Approval: MPAC (01/20/2026); Effective: 04/01/2026.
- Follow the plan’s authorization processes and SPD language when submitting requests for approval.
Pharmacy and hormone coverage — consult formularies
Consult plan pharmacy formularies and the member's SPD for coverage and any plan-specific requirements for puberty suppression and gender-affirming hormone therapy.
- Pharmacy/formulary coverage and any utilization management requirements (e.g., prior authorization) are determined by the plan formulary referenced in Section III.
Document collaborative multidisciplinary agreement before surgery
Before referral for genital gender-affirming surgery, obtain collaborative documentation showing agreement between the mental health professional and the clinician responsible for endocrine therapy that surgery is medically necessary.
- WPATH and Endocrine Society guidance recommend that the mental health professional and the clinician responsible for endocrine treatment agree that genital surgery is medically necessary prior to referral.
- Document multidisciplinary collaboration (mental health, endocrine, surgical) especially for adolescent referrals.
No step therapy rules in excerpt
No step therapy rules for gender-affirming treatments or medications are detailed in the provided excerpt.
- The policy does not specify step therapy requirements in the shown sections; review the full policy or plan documents for any plan-specific pharmacy management rules.
Coding and documentation note — excerpt lists codes but not templates
The document lists CPT/HCPCS codes and policy header information but this excerpt does not include specific additional documentation templates or forms beyond the letter of medical necessity requirements.
- Coding disclaimer: inclusion of codes is informational and does not itself indicate coverage; benefits are determined by the member's SPD.
- Adherence may be monitored via post-payment review or audits.
Required documentation: referral / letter of medical necessity
A referral/letter of medical necessity from a qualified licensed healthcare professional is required and must document that the member meets diagnostic criteria, that gender dysphoria/incongruence is marked and sustained, capacity for informed consent, understanding of reproductive effects and fertility options, exclusion of other causes, and assessment of coexisting mental/physical conditions.
- For adults, letters must also document duration and, for gonadectomy, six months of hormone therapy unless hormone therapy is not desired or is medically contraindicated.
- For adolescents, a comprehensive biopsychosocial assessment by qualified mental health and medical professionals is required and the letter must address capacity, maturity, and fertility counseling.
Multidisciplinary documentation recommended
Clinical determinations should be made by qualified professionals and multidisciplinary documentation (mental health, endocrine, surgical team) is recommended, particularly for adolescents and for genital surgeries.
- WPATH SOC-8 and Endocrine Society guidelines are referenced as the clinical guidance supporting multidisciplinary assessment.
- In adolescents, an expert multidisciplinary team is endorsed; in its absence, recommended collaboration between pediatric endocrinologist, mental health professional, and other providers.
Excerpt lacks further documentation detail
This excerpt primarily lists procedure codes and policy header information and does not contain additional documentation requirements beyond those for letters of medical necessity and multidisciplinary assessment.
- Refer to the full policy for any additional forms, checklists, or required supporting clinical records.
Include ICD-10 gender identity codes with requests/claims
Use the listed ICD-10 diagnosis codes related to gender identity (F64.0, F64.2, F64.8, F64.9) and Z87.890 (personal history of sex reassignment) as supporting diagnosis codes when submitting authorization requests and claims.
- These ICD-10 codes are provided for informational purposes and are expected to accompany claims and documentation for gender-affirming procedures.
Cite supporting clinical references in documentation
References and clinical literature (e.g., WPATH SOC-8, Endocrine Society guideline, UpToDate chapters, systematic reviews) are cited in the policy and should be used to support clinical rationale in authorization documentation.
- Cite WPATH SOC-8 and Endocrine Society guidance when clinical assessments reference standard-of-care recommendations.
- Include relevant literature citations in complex or case-by-case authorization requests as appropriate.
Pharmacy/medication coverage — check plan formulary
For puberty suppression and gender-affirming hormone coverage, consult the plan’s pharmacy formulary and SPD for any medication authorization or utilization management requirements.
- Pharmacy coverage details (including prior authorization) are determined by Employer Health Programs formulary guidance referenced in Section III.
Document collaborative care before surgical referral
Prior to surgical referral, ensure documented collaboration and agreement between mental health and endocrine clinicians that surgery is appropriate and that risks, timing, and hormone management are addressed.
- Document that the clinician responsible for endocrine treatment and the mental health professional both concur surgery is medically necessary for genital procedures.
- For adolescents, ensure documentation of multidisciplinary team input or documented collaboration per WPATH SOC-8.
No step therapy rules provided
The policy excerpt contains no step therapy requirements or sequencing rules for gender-affirming medications or interventions.
- If step therapy or other pharmacy management rules are suspected, verify in the full policy or the member’s SPD/formulary.
Coding mismatch risk — match billed codes to policy lists
Ensure procedural coding matches the listed CPT/HCPCS codes in the policy; miscoding of procedures such as hysterectomy, vaginectomy, oophorectomy, or urethroplasty may lead to claim denials or processing issues.
- Use the policy’s coding tables when assigning CPT/HCPCS codes to gender-affirming surgical claims.
- Be aware the coding disclaimer states inclusion of codes is informational and benefit coverage is determined by the member’s SPD.
No changes to policy criteria
There are no changes to the policy criteria in the current revision; authorization criteria remain as previously stated.
- Revision history (01/20/2026) notes: 'No changes to policy criteria.'
Background and Scope
Gender-affirming treatments described in the policy are provided when a qualified clinician establishes a diagnosis of Gender Dysphoria per DSM-5-TR criteria and when multidisciplinary assessment supports treatment. The background notes that evidence supports benefits of gender-affirming surgery for appropriately selected individuals and references WPATH SOC-8 as a primary guidance source for clinical decision-making and the need for multidisciplinary collaboration.
Definitions and Key Terms
Revision History
Policy approved by the Medical Policy Advisory Committee (MPAC); signature on file.
Policy becomes effective and supersedes the prior version dated 2025-04-01.
Previous version of this policy (superseded by the 2026 revision) noted as the superseded date in the document header.
The Summary of Changes for the 01/20/2026 revision states there were no changes to policy criteria. This indicates that the existing eligibility requirements, exclusions, and coverage logic remain in force for this version; administrative or presentation elements may have been updated but criteria were unchanged.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.